TCL Archive Patent Policies Need Revision, Study of Hopkins, CellPro Dispute Concludes; January 10, 2003
TCL Archive Center Core Grants Picture Less Bleak; Competing Renewals To Receive 50% Of Recommended Increases January 4, 1980
TCL Archive Abraxane-Gemcitabine Combination Extends Overall Survival in Phase III Trial January 31, 2014
TCL Archive Genentech Reps Not Welcome: Hospitals Urge Drug Maker to Reverse Policy On Supplying Avastin, Rituxan, & Herceptin October 17, 2014
TCL Archive In Brief: NCI Award 14 Contracts to Operate The Cancer Information Service August 13, 1999
